Capital Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,703
Closed -$910K 590
2022
Q3
$910K Sell
3,703
-14
-0.4% -$3.78K 0.03% 252
2022
Q2
$920K Buy
3,717
+2
+0.1% +$540 0.03% 257
2022
Q1
$1.23M Hold
3,715
0.04% 240
2021
Q4
$1.33M Hold
3,715
0.04% 237
2021
Q3
$1.21M Buy
3,715
+10
+0.3% +$3.39K 0.04% 243
2021
Q2
$1.16M Buy
3,705
+145
+4% +$44.5K 0.04% 246
2021
Q1
$1.14M Sell
3,560
-71
-2% -$22.7K 0.04% 236
2020
Q4
$1.18M Sell
3,631
-3
-0.1% -$830 0.05% 220
2020
Q3
$1.01M Sell
3,634
-165
-4% -$47.5K 0.05% 225
2020
Q2
$918K Sell
3,799
-185
-5% -$37.1K 0.05% 230
2020
Q1
$578K Buy
3,984
+222
+6% +$36.9K 0.04% 262
2019
Q4
$642K Sell
3,762
-63
-2% -$11.7K 0.03% 286
2019
Q3
$680K Buy
+3,825
New +$827K 0.04% 269

Other funds holding ABMD

Capital Investment Advisors's ABMD Position: Q4 2022 in Review

Capital Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,703 shares — an estimated $910K sold.

Capital Investment Advisors first reported a position in ABMD in Q3 2019 and held it in 13 quarters. The position peaked at $1.33M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Capital Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Capital Investment Advisors sold 3,703 Abiomed Inc shares in Q4 2022, an estimated $910K.
  • Capital Investment Advisors first reported a position in Abiomed Inc in Q3 2019 and held it in 13 quarters.
  • Capital Investment Advisors's Abiomed Inc position peaked at $1.33M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Capital Investment Advisors's 13F filing for Q4 2022, filed 5 Jan 2023.